Arizona Bioscience News: UA licenses tech for new colonoscopy instrument; AZBio initiative to raise endowment; Arizona SciTech Festival events continue

May 17, 2018

By Matt Ellsworth

UA licenses tech for new colonoscopy instrument / Arizona Daily Star

Omniscient, a University of Arizona startup, is looking to vastly improve the accuracy of colonoscopies with a new type of endoscope that offers 360-degree views of the colon.

UA study uses ‘social networking’ of cells to find cure for cancer / KGUN

A University of Arizona Cancer Center researcher has developed a computer algorithm called ALPACA that reveals which gene networks are activated in a diseased cell, an approach that could lead to better treatments for various diseases.

[Want to get this news digest via email each week? Signing up will take just a moment.]

AZBio initiative aims to cure funding gap that ails Arizona / AZ Big Media

The leaders of a coalition of nonprofit organizations talk about their plan to raise a $200 million endowment to support the commercialization of life-changing and lifesaving health care innovations that are being developed by Arizona-based researchers and entrepreneurs.

Kids ‘Xplor’ science, tech in Verde Valley /

A day-long exhibition, part of the Arizona SciTech Festival, brought students from the Verde Valley and Sedona together to meet professionals with careers in science, technology, engineering, art and math with the aim to catch kids’ interest in STEAM. Read also: People & Places: Marshmallow fling, planetarium, electric vehicles, all part of science festival

Canadian manufacturing company opens facility in Mesa / Phoenix Business Journal

Canada-based Eclipse Automation, which offers custom machine and design build and custom robotics and engineering for companies working in health science, aerospace, electronics and energy, has opened a Mesa manufacturing facility with plans to invest another $1 million within the next 16 months.

TGen develops quality-control test for detecting cancer in blood / AZ Big Media

A scientific team led by the Translational Genomics Research Institute has devised a rapid blood test that has shown promising results in helping evaluate biomarkers in several cancer types, including melanoma, cholangiocarcinoma, rectal cancer and breast cancer.